Limits...
In vivo Anticancer Activities of Benzophenone Semicarbazone against Ehrlich Ascites Carcinoma Cells in Swiss Albino Mice.

Islam K, Ali SM, Jesmin M, Khanam JA - Cancer Biol Med (2012)

Bottom Line: The results showed that BSC has a positive effect against EAC cells.An assessment was conducted by comparing these results with those obtained using the standard drug bleomycin.The BSC compound can be considered as a potent anticancer agent.

View Article: PubMed Central - PubMed

Affiliation: Department of Applied Chemistry and Chemical Engineering, University of Rajshahi, Rajshahi 6205, Bangladesh.

ABSTRACT

Objective: Benzophenone semicarbazone (BSC) was synthesized and characterized to identify compounds with anticancer activities.

Methods: Anticancer activities were studied against Ehrlich Ascites Carcinoma (EAC) cells in Swiss albino mice by monitoring parameters such as tumor weight measurement, survival time of tumor bearing mice, tumor cell growth inhibition, and so on. Some hematological parameters, such as red blood cells, white blood cells, and hemoglobin content, were also measured.

Results: The results showed that BSC has a positive effect against EAC cells. An assessment was conducted by comparing these results with those obtained using the standard drug bleomycin.

Conclusions: The BSC compound can be considered as a potent anticancer agent.

No MeSH data available.


Related in: MedlinePlus

Effect of BSC [at 5, 15, and 25 mg/kg (i.p.)] on average tumor weight. Data are expressed as the mean of the results from 4 mice. Treatment was continued for 10 consecutive days.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3643672&req=5

f1: Effect of BSC [at 5, 15, and 25 mg/kg (i.p.)] on average tumor weight. Data are expressed as the mean of the results from 4 mice. Treatment was continued for 10 consecutive days.

Mentions: The effects of the test compound at different doses and the standard antitumor drug bleomycin (0.3 mg/kg) on the tumor weight are graphed in Figure 1. The treatments of the animals previously inoculated with EAC cells with the test compound resulted in tumor growth inhibition.


In vivo Anticancer Activities of Benzophenone Semicarbazone against Ehrlich Ascites Carcinoma Cells in Swiss Albino Mice.

Islam K, Ali SM, Jesmin M, Khanam JA - Cancer Biol Med (2012)

Effect of BSC [at 5, 15, and 25 mg/kg (i.p.)] on average tumor weight. Data are expressed as the mean of the results from 4 mice. Treatment was continued for 10 consecutive days.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3643672&req=5

f1: Effect of BSC [at 5, 15, and 25 mg/kg (i.p.)] on average tumor weight. Data are expressed as the mean of the results from 4 mice. Treatment was continued for 10 consecutive days.
Mentions: The effects of the test compound at different doses and the standard antitumor drug bleomycin (0.3 mg/kg) on the tumor weight are graphed in Figure 1. The treatments of the animals previously inoculated with EAC cells with the test compound resulted in tumor growth inhibition.

Bottom Line: The results showed that BSC has a positive effect against EAC cells.An assessment was conducted by comparing these results with those obtained using the standard drug bleomycin.The BSC compound can be considered as a potent anticancer agent.

View Article: PubMed Central - PubMed

Affiliation: Department of Applied Chemistry and Chemical Engineering, University of Rajshahi, Rajshahi 6205, Bangladesh.

ABSTRACT

Objective: Benzophenone semicarbazone (BSC) was synthesized and characterized to identify compounds with anticancer activities.

Methods: Anticancer activities were studied against Ehrlich Ascites Carcinoma (EAC) cells in Swiss albino mice by monitoring parameters such as tumor weight measurement, survival time of tumor bearing mice, tumor cell growth inhibition, and so on. Some hematological parameters, such as red blood cells, white blood cells, and hemoglobin content, were also measured.

Results: The results showed that BSC has a positive effect against EAC cells. An assessment was conducted by comparing these results with those obtained using the standard drug bleomycin.

Conclusions: The BSC compound can be considered as a potent anticancer agent.

No MeSH data available.


Related in: MedlinePlus